Influence of reduced glutathione on end-joining of DNA double-strand breaks: Cytogenetical and molecular approach
Creators
- 1. Molecular Genetics Laboratory, Department of Biotechnology & Bioinformatics, North-Eastern Hill University, Shillong, Meghalaya-793022 (India)
- 2. Department of Biochemistry, Indian Institute of Science, Bangalore, 560 012 (India)
Description
Highlights: • DNA lesions induced by Blem and radiation interact well and form higher frequency of exchange aberrations. • Cellular level of glutathione does influence such interaction of DNA lesions. • Oligomer-based cell-free assay system demonstrated better end-joining efficiency at higher level of endogenous GSH. - Abstract: Radiation induced DNA double-strand breaks (DSB) are the major initial lesions whose misrejoining may lead to exchange aberrations. However, the role of glutathione (GSH), a major cellular thiol, in regulating cell's sensitivity to DNA damaging agents is not well understood. Influence of endogenous GSH on the efficiency of X-rays and bleomycin (Blem) induced DNA DSBs end-joining has been tested here cytogenetically, in human lymphocytes and Hct116 cells. In another approach, oligomeric DNA (75 bp) containing 5′-compatible and non-compatible overhangs mimicking the endogenous DSB were for rejoining in presence of cell-free extracts from cells having different endogenous GSH levels. Frequency of aberrations, particularly exchange aberrations, was significantly increased when Blem was combined with radiation. The exchange aberration frequency was further enhanced when combined treatment was given at 4 °C since DNA lesions are poorly repaired at 4 °C so that a higher number of DNA breaks persist and interact when shifted from 4 °C to 37 °C. The exchange aberrations increased further when the combined treatment was given to Glutathione-ester (GE) pre-treated cells, indicating more frequent rejoining of DNA lesions in presence of higher cellular GSH. This is further supported by the drastic reduction in frequency of exchange aberrations but significant increase in incidences of deletions when combined treatment was given to GSH-depleted cells. End-joining efficiency of DNA DSBs with compatible ends was better than for non-compatible ends. End-joining efficiency of testicular and MCF7 cell extracts was better than that of lungs and Hct116 cells. Cell extract made from GE-treated MCF-7 cells provided more efficient end-joining than from untreated and GSH-depleted cells. However, direct addition of GSH to the cell-free extracts showed considerable reduction in end-joining efficiency. Present data indicate that higher endogenous GSH favours rejoining of DNA DSBs (both restitution and illegitimate reunion) which in turn produce more exchange aberrations.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.mrfmmm.2016.10.005Additional details
Identifiers
- DOI
- 10.1016/j.mrfmmm.2016.10.005;
- PII
- S0027-5107(16)30055-0;
Publishing Information
- Journal Title
- Mutation Research
- Journal Volume
- 795
- Journal Page Range
- p. 1-9
- ISSN
- 0027-5107
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 49033810
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- BORON PHOSPHIDES; CHROMOSOMAL ABERRATIONS; CHROMOSOMES; DNA; ESTERS; GLUTATHIONE; HUMAN POPULATIONS; INTERACTIONS; LUNGS; LYMPHOCYTES; REPAIR; SENSITIVITY; STRAND BREAKS; TESTES; THIOLS; X RADIATION
- Descriptors DEC
- ANIMAL CELLS; BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY; BODY FLUIDS; BORON COMPOUNDS; CONNECTIVE TISSUE CELLS; DNA DAMAGES; DRUGS; ELECTROMAGNETIC RADIATION; GONADS; IONIZING RADIATIONS; LEUKOCYTES; MALE GENITALS; MATERIALS; MUTATIONS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANIC SULFUR COMPOUNDS; ORGANS; PEPTIDES; PHOSPHIDES; PHOSPHORUS COMPOUNDS; PNICTIDES; POLYPEPTIDES; POPULATIONS; PROTEINS; RADIATIONS; RADIOPROTECTIVE SUBSTANCES; RESPIRATORY SYSTEM; RESPONSE MODIFYING FACTORS; SOMATIC CELLS
Optional Information
- Copyright
- Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.